Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

ArriVent BioPharma Stock News

AVBPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$18.14

0.241.34%

At close: -

$18.14

0.000.00%

After Hours: Apr 17, 4:00 PM EDT

ArriVent BioPharma (AVBP) Forecast

News

Earnings ArriVent BioPharma (AVBP) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest ArriVent BioPharma Stock News | NASDAQ:AVBP | Benzinga

Get the latest news on ArriVent BioPharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ArriVent BioPharma performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 20, 2025

ArriVent Lead Drug Candidate Shows Promise In Lung Cancer Type, Analyst Sees Over 50% Upside
Vandana Singh - Mar 20, 2025, 2:54PM
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor - Mar 20, 2025, 9:55AM
B. Riley Securities Initiates Coverage On Arr...
Benzinga Newsdesk - Mar 20, 2025, 5:17AM

Monday, March 10, 2025

Guggenheim Initiates Coverage On ArriVent Bio...
Benzinga Newsdesk - Mar 10, 2025, 10:58AM

Friday, March 07, 2025

HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk - Mar 7, 2025, 7:35AM

Monday, March 03, 2025

ArriVent BioPharma 2024 Net Loss $80.5M; Cash...
Benzinga Newsdesk - Mar 3, 2025, 7:20AM

Monday, January 27, 2025

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Jan 27, 2025, 4:45AM

Wednesday, January 22, 2025

HC Wainwright & Co. Maintains Buy on ArriVent...
Benzinga Newsdesk - Jan 22, 2025, 7:49AM
ArriVent BioPharma Entered Exclusive License ...
Benzinga Newsdesk - Jan 21, 2025, 7:06PM

Thursday, January 16, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jan 16, 2025, 4:05PM

Friday, November 15, 2024

HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk - Nov 15, 2024, 6:26AM

Thursday, November 14, 2024

ArriVent BioPharma shares are trading lower. ...
Benzinga Newsdesk - Nov 14, 2024, 11:44AM
ArriVent BioPharma Q3 EPS $(0.61) Beats $(0.8...
Benzinga Newsdesk - Nov 14, 2024, 8:30AM

Wednesday, September 11, 2024

Citigroup Maintains Buy on ArriVent BioPharma...
Benzinga Newsdesk - Sep 11, 2024, 12:18PM

Tuesday, September 10, 2024

Oppenheimer Reiterates Outperform on ArriVent...
Benzinga Newsdesk - Sep 10, 2024, 11:23AM
Goldman Sachs Maintains Buy on ArriVent BioPh...
Benzinga Newsdesk - Sep 10, 2024, 9:55AM
HC Wainwright & Co. Maintains Buy on ArriVent...
Benzinga Newsdesk - Sep 10, 2024, 7:08AM

Monday, September 09, 2024

ArriVent Announces Proof-Of-Concept Global Ph...
Benzinga Newsdesk - Sep 9, 2024, 12:07PM

Monday, August 19, 2024

Here's What Could Help ArriVent BioPharma, Inc. Maintain Its Recent Price Strength
Zacks - Aug 19, 2024, 2:00PM

Friday, August 16, 2024

HC Wainwright & Co. Maintains Buy on ArriVent...
Benzinga Newsdesk - Aug 16, 2024, 6:42AM

Thursday, August 15, 2024

Oppenheimer Reiterates Outperform on ArriVent...
Benzinga Newsdesk - Aug 15, 2024, 9:53AM

Wednesday, August 14, 2024

ArriVent BioPharma Q2 EPS $(0.65) Misses $(0....
Benzinga Newsdesk - Aug 14, 2024, 4:08PM

Monday, August 12, 2024

ArriVent Presents Proof-Of-Concept Phase 1b D...
Benzinga Newsdesk - Aug 12, 2024, 8:10AM

Thursday, June 06, 2024

HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk - Jun 6, 2024, 6:13AM

Wednesday, June 05, 2024

ArriBent BioPharma Has Collaborated With Jian...
Benzinga Newsdesk - Jun 5, 2024, 7:09AM

Thursday, May 09, 2024

HC Wainwright & Co. Reiterates Buy on ArriVen...
Benzinga Newsdesk - May 9, 2024, 7:14AM

Wednesday, May 08, 2024

ArriVent BioPharma Q1 EPS $(0.70) Beats $(1.0...
Benzinga Newsdesk - May 8, 2024, 8:15AM

Tuesday, April 30, 2024

HC Wainwright & Co. Initiates Coverage On Arr...
Benzinga Newsdesk - Apr 30, 2024, 6:12AM

Monday, April 08, 2024

ProfoundBio Discovers The Joys Of Having A Wealthy Owner
The Bamboo Works - Apr 8, 2024, 11:43AM

Thursday, March 28, 2024

ArriVent BioPharma FY23 EPS $(32.38) Vs $(28....
Benzinga Newsdesk - Mar 28, 2024, 4:38PM

Tuesday, February 20, 2024

Jefferies Initiates Coverage On ArriVent BioP...
Benzinga Newsdesk - Feb 20, 2024, 11:37AM
Citigroup Initiates Coverage On ArriVent BioP...
Benzinga Newsdesk - Feb 20, 2024, 6:50AM
Goldman Sachs Initiates Coverage On ArriVent ...
Benzinga Newsdesk - Feb 20, 2024, 5:47AM

Friday, February 02, 2024

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor - Feb 2, 2024, 8:56AM

Friday, January 26, 2024

ArriVent BioPharma Inc IPO Opens At $24.00
Benzinga Newsdesk - Jan 26, 2024, 12:34PM
ArriVent BioPharma Shares Indicating $24.00 O...
Benzinga Newsdesk - Jan 26, 2024, 12:28PM
ArriVent BioPharma Shares Indicating $23.50 O...
Benzinga Newsdesk - Jan 26, 2024, 11:58AM
ArriVent BioPharma Shares Indicating $23.00 O...
Benzinga Newsdesk - Jan 26, 2024, 11:52AM
ArriVent BioPharma Shares Indicating $20.50 O...
Benzinga Newsdesk - Jan 26, 2024, 11:10AM
ArriVent BioPharma Shares Indicating $20 On 1...
Benzinga Newsdesk - Jan 26, 2024, 10:55AM
ArriVent BioPharma Shares Indicating $20 On 8...
Benzinga Newsdesk - Jan 26, 2024, 10:41AM
ArriVent BioPharma Prices Upsized Initial Pub...
Benzinga Newsdesk - Jan 26, 2024, 2:18AM

Thursday, January 25, 2024

Arrivent Biopharma, Inc To Start Trading Tomorrow
Benzinga Insights - Jan 25, 2024, 10:00AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved